REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Enimmune Corporation (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Enimmune Corporation Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Enimmune Corp. is a joint venture research and development and marketing company jointly established by Guoguang Biotech and Venture Capital. Its first product is Enterovirus 71 vaccine. The company was founded in 2014 and is headquartered in Taipei City, Taiwan.

Headquarters
18F.-2, No. 76, Sec. 2, Dunhua S. Rd., Da'An Dist
Taipei City; Taipei City;

Contact Details: Purchase the Enimmune Corporation report to view the information.

Website: http://www.enimmune.com.tw

Basic Information
Total Employees:
Purchase the Enimmune Corporation report to view the information.
Outstanding Shares:
Purchase the Enimmune Corporation report to view the information.
Financial Auditors:
Purchase the Enimmune Corporation report to view the information.
Incorporation Date:
January 10, 2014
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
2.45%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Enimmune-Rmt Biotech Pte.Ltd. (Singapore)
55%
Company Performance
Financial values in the chart are available after Enimmune Corporation report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
56.35%▲
Total operating revenue
68.89%▲
Operating profit (EBIT)
-1.46%▼
EBITDA
15.04%▲
Net Profit (Loss) for the Period
-5.91%▼
Total assets
10.7%▲
Total equity
-5.81%▼
Operating Profit Margin (ROS)
238.99%▲
Net Profit Margin
211.78%▲
Return on Equity (ROE)
-1.82%▼
Debt to Equity Ratio
11.66%▲
Quick Ratio
-1.42%▼
Cash Ratio
-0.62%▼

Similar companies

Lotus Pharmaceutical Co., Ltd.
 
Great Tree Pharmacy Co.,Ltd.
Bora Pharmaceuticals Co., Ltd.
 
China Chemical & Pharmaceutical Co., Ltd
PharmaEssentia Corp.
 
Pharmally International Holding Co., Ltd
Caliway Biopharmaceuticals Co., Ltd.
 
PharmaCore Biotech Co., Ltd.
Innopharmax Inc.
 
Intech Biopharm Ltd.
AP Biosciences Inc
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo